News & Updates

Daily intake of rice bran extract supplements (RBS) appears effective in reducing depressive symptoms in adults with mild-to-moderate symptom severity, reports a study, noting improvements reaching clinically relevant thresholds.

Disease burden has significantly increased because of the COVID-19 pandemic, particularly mental health disorders, malaria in young children in the African region, and stroke and ischaemic heart disease in older adults, reports a study.

Intranasal esketamine, administered at two fixed doses as monotherapy for treatment-resistant depression (TRD), has demonstrated robust and rapid efficacy in a phase IV double-blind, placebo-controlled randomized trial.

Attention-deficit/hyperactivity disorder (ADHD) medications are associated with reduced risks of several serious real-world outcomes, but the magnitude of these associations has decreased alongside rising prescription rates, a nationwide study has shown.